The Latest Cardiac and Vascular News
PARIS–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device (LVAD) operating synchronously with the native heart without the use of sensors. The results were presented at the […]
Remote blood pressure monitoring service standardizes BP collection PHILADELPHIA, June 14, 2021 /PRNewswire/ — ERT, the global leader in clinical endpoint data collection, today announced the expansion of its clinical trial endpoint data collection portfolio with at-home blood pressure (BP) monitoring solution. This completes a suite of blood pressure assessment services developed by […]
Positive Data from Completed InRhythm Phase 2 Study Demonstrate Safe and Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Plans to Initiate RESTORE1: Single Pivotal Phase 3 Trial in Atrial Fibrillation in Q3 2021; Data Expected 2H 2022 Appointment of Angela Wang as CFO Strengthens Management Team and Supports […]
Publication in JAMA Shows Reveal LINQ™ ICM Demonstrated a Seven-Fold Increase in Detecting AF vs. Standard of Care DUBLIN, June 7, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal LINQ™ Insertable Cardiac Monitor […]
– First-of-its-kind steerable delivery system designed for left atrial appendage (LAA) occluder to seal the LAA in people who are at increased risk of stroke due to atrial fibrillation – New delivery system works with Abbott’s leading Amplatzer Amulet™ LAA Occluder device to enable better access to the LAA and […]
Agreement Expands Access to Cardea SOLO™ Digital Health Solution for Early Atrial Fibrillation Detection and Diagnosis BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc. (“Cardiac Insight” or the “Company) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to detect arrythmias, including atrial fibrillation. […]
Issuance of Its Newest U.S. Patent Will Strengthen Anavex’s Compounds Intellectual Property Portfolio NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s […]
Dreamtech distributes Cardea SOLO™ ECG System in Korea through its new healthcare organization iSigNal, and lead commercial expansion in 20+ other APAC countries. BELLEVUE, Wash. & SEONGNAM, South Korea–(BUSINESS WIRE)–Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software announced today that […]
– China Grand Pharma will seek regulatory approvals and commercialize CardioFocus’ innovative catheter ablation technology for pulmonary vein isolation – Pulmonary vein isolation is the gold standard treatment for atrial fibrillation MARLBOROUGH, Mass., June 2, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), […]
IRVINE, Calif., June 1, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff has received U.S. Food and Drug Administration clearance. This is the first noninvasive solution that unlocks Acumen HPI software and uses machine learning to alert clinicians of the […]
